Mitochondrial Respiratory Chain Deficiencies Clinical Trial
Official title:
Study of Interaction Between Adipose and Muscle Tissues in the Control of Muscle Mitochondrial Functions
Numerous studies have demonstrated that excess perivisceral adipose tissue is associated
with metabolic diseases such as insulin resistance.
In skeletal muscle, insulin resistance has been correlated with reduced mitochondrial
oxidative functions. According to the actual theory, mitochondrial dysfunctions are proposed
to play a causal role in the aetiology of insulin resistance. Mechanisms involve increased
intramyocellular lipids storage. Yet, the causes responsible for the decline in muscle
mitochondrial functions remain to be elucidated.
The investigators hypothesize that these alterations are induced by combined changes in
plasma profiles of lipids and adipokines, which originate from perivisceral adipose tissue.
The study aims at answering the following questions :
- Are muscle mitochondrial functions altered in association with increased perivisceral
adipose tissue storage?
- Do changes in the pattern of plasma lipids and adipokines explain this correlation?
Sixty 35 to 50-years old sedentary men will be included based on their abdominal
circumference (from 75 to over 102 cm).
Body composition will be evaluated using dual-energy X-ray absorptiometry and perivisceral,
intramuscular and intrahepatic adiposity will be assess by MRI and proton-NMR spectroscopy.
Subjects will be also characterized by their glucose tolerance (OGTT), basal metabolism
(indirect calorimetry) and maximal oxygen consumption (maximal aerobic power test on
exercise bike).
Blood samples will be collected in the fasted state to assess lipids and adipokines
concentrations.
Biopsies will be obtained from the vastus lateralis muscle to examine mitochondrial
functions (respiration rates, ATP and superoxide anion production rates, maximal activity of
oxidative enzyme). Gene expression of key enzymes, protein and transcription factors
involved in lipid and energy metabolism will be assessed using real-time quantitative PCR.
Finally, whole body and muscle protein metabolism will be investigated in half of the
subjects using tracer infusion (incorporation of L-[1-13C]leucine) and biopsies from vastus
lateralis, both in the post-absorptive and post-prandial states (test meal)
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03888716 -
A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease
|
Phase 1 | |
| Completed |
NCT03056209 -
Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers
|
Phase 1 |